170 related articles for article (PubMed ID: 25435723)
21. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
[TBL] [Abstract][Full Text] [Related]
22. Optical Genome Mapping Reveals the Complex Genetic Landscape of Myeloma.
Giguère A; Raymond-Bouchard I; Collin V; Claveau JS; Hébert J; LeBlanc R
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835381
[TBL] [Abstract][Full Text] [Related]
23. Amp 1q21 is more predictable with dismal survival than gain 1q21 of newly diagnosed multiple myeloma in real-world analysis.
Wang YT; Bao L; Chu B; Chen XH; Lu MQ; Shi L; Gao S; Fang LJ; Xiang QQ; Ding YH
J Clin Lab Anal; 2022 Jul; 36(7):e24375. PubMed ID: 35353920
[TBL] [Abstract][Full Text] [Related]
24. Comparison of IGH Profile Signals Using t(4;14) and IGH Break-Apart Probes by FISH in Multiple Myeloma.
Smol T; Daudignon A
Cytogenet Genome Res; 2017; 153(1):18-21. PubMed ID: 29040969
[TBL] [Abstract][Full Text] [Related]
25. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
[TBL] [Abstract][Full Text] [Related]
26. Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH).
Ritterbach J; Hiddemann W; Beck JD; Schrappe M; Janka-Schaub G; Ludwig WD; Harbott J; Lampert F
Leukemia; 1998 Mar; 12(3):427-33. PubMed ID: 9529139
[TBL] [Abstract][Full Text] [Related]
27. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
Chng WJ; Santana-Dávila R; Van Wier SA; Ahmann GJ; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Jacobus S; Blood E; Oken MM; Henderson K; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Greipp PR; Fonseca R
Leukemia; 2006 May; 20(5):807-13. PubMed ID: 16511510
[TBL] [Abstract][Full Text] [Related]
29. Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics.
Cremer FW; Bila J; Buck I; Kartal M; Hose D; Ittrich C; Benner A; Raab MS; Theil AC; Moos M; Goldschmidt H; Bartram CR; Jauch A
Genes Chromosomes Cancer; 2005 Oct; 44(2):194-203. PubMed ID: 16001433
[TBL] [Abstract][Full Text] [Related]
30. Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion.
Hao S; Lin P; Medeiros LJ; Fang L; Carballo-Zarate AA; Konoplev SN; Sargent RL; Weber DM; Thomas SK; Manasanch EE; Orlowski RZ; Lu X
Mod Pathol; 2017 Oct; 30(10):1378-1386. PubMed ID: 28664940
[TBL] [Abstract][Full Text] [Related]
31. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations.
Kadam Amare P; Nikalje Khasnis S; Hande P; Lele H; Wable N; Kaskar S; Nikam Gujar N; Gardi N; Prabhudesai A; Todi K; Waghole R; Roy P
Cytogenet Genome Res; 2022; 162(10):529-540. PubMed ID: 36780889
[TBL] [Abstract][Full Text] [Related]
33. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
[TBL] [Abstract][Full Text] [Related]
34. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Implications of Monosomies in Patients With Multiple Myeloma.
Shin SY; Eom HS; Sohn JY; Lee H; Park B; Joo J; Jang JH; Lee MN; Kim JK; Kong SY
Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):159-164.e2. PubMed ID: 28089441
[TBL] [Abstract][Full Text] [Related]
36. Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia.
Hwang Y; Lee JY; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2011 Jun; 33(3):299-304. PubMed ID: 21272268
[TBL] [Abstract][Full Text] [Related]
37. Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse.
Smetana J; Oppelt J; Štork M; Pour L; Kuglík P
Mol Cytogenet; 2018; 11():7. PubMed ID: 29375670
[TBL] [Abstract][Full Text] [Related]
38. [Immunoglobulin M multiple myeloma: a six-case report and literature review].
Yan WW; Fan HS; Xu JY; Liu JH; Du CX; Deng SH; Sui WW; Xu Y; Qiu LG; An G
Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):1011-1014. PubMed ID: 35045672
[No Abstract] [Full Text] [Related]
39. The prognostic impact of t(11;14) in multiple myeloma: A real-world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR).
Lim KJ; Wellard C; Talaulikar D; Tan JL; Loh J; Puvanakumar P; Kuzich JA; Ho M; Murphy M; Zeglinas N; Low MS; Routledge D; Lim AB; Gibbs SD; Quach H; Morgan S; Moore E; Ninkovic S
EJHaem; 2023 Aug; 4(3):639-646. PubMed ID: 37601874
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization.
Hu Y; Chen W; Chen S; Huang Z
Onco Targets Ther; 2016; 9():1145-9. PubMed ID: 27042105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
